Anne Wojcicki (23andMe) - Driving Discovery and Disruption
Entrepreneurial Thought Leaders (ETL)
00:00
How to Translate Insights From Data Into Potentially Drug Targets
The company has seven compounds or seven targets under development. "We don't start with a specific hypothesis," says CEO and co-founder of Survey Methodology, Richard Scheller. "In some ways for me, not having a PhD or an MD was helpful because you can think"
Play episode from 24:31
Transcript
